Lipid Nanoparticle-Mediated Vascular-Disrupting Therapy for Lung Metastasis
Biological and Pharmaceutical Bulletin · 2026
DOI: 10.1248/bpb.b26-00306 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biological and Pharmaceutical Bulletin, 2026. Verfasst von Tomoki Ueda und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmaceutical Sciences, Hokkaido University, Kita 12, Nishi 6, Kita-ku, Sapporo 060-0812, Japan. Hauptthemen laut MEDLINE: Lung Neoplasms, Nanoparticles, RNA, Small Interfering, Peptides, Cyclic. Die Arbeit nennt 39 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Pharmaceutical Sciences, Hokkaido University, Kita 12, Nishi 6, Kita-ku, Sapporo 060-0812, Japan.
- Faculty of Pharmacy, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kakuma-machi, Kanazawa, Ishikawa 920-1192, Japan.
Zitieren
APA
Ueda, T., Endo, R., Sato, Y., Harashima, H., Yamada, Y., & Nakamura, T. (2026). Lipid Nanoparticle-Mediated Vascular-Disrupting Therapy for Lung Metastasis. Biological and Pharmaceutical Bulletin. https://doi.org/10.1248/bpb.b26-00306
Vancouver
Ueda T, Endo R, Sato Y, Harashima H, Yamada Y, Nakamura T. Lipid Nanoparticle-Mediated Vascular-Disrupting Therapy for Lung Metastasis. Biological and Pharmaceutical Bulletin. 2026. doi:10.1248/bpb.b26-00306
BibTeX
@article{Ueda2026,
author = {Ueda, Tomoki and Endo, Rikito and Sato, Yusuke and Harashima, Hideyoshi and Yamada, Yuma and Nakamura, Takashi},
title = {Lipid Nanoparticle-Mediated Vascular-Disrupting Therapy for Lung Metastasis},
journal = {Biological and Pharmaceutical Bulletin},
year = {2026},
doi = {10.1248/bpb.b26-00306}
}
EUVIMED